Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.

@article{Lipshultz2013PediatricCC,
  title={Pediatric cardiomyopathies: causes, epidemiology, clinical course, preventive strategies and therapies.},
  author={Steven E. Lipshultz and Thomas R. Cochran and David A. Briston and Stefanie R Brown and Peter J Sambatakos and Tracie L. Miller and Adriana Alejandra Carrillo and Liat Corcia and Janine E Sanchez and Melissa B Diamond and Michael Freundlich and Danielle Harake and Tamara L. Gayle and William G. Harmon and Paolo G. Rusconi and Satinder K. Sandhu and James Dean Wilkinson},
  journal={Future cardiology},
  year={2013},
  volume={9 6},
  pages={817-48}
}
Pediatric cardiomyopathies, which are rare but serious disorders of the muscles of the heart, affect at least one in every 100,000 children in the USA. Approximately 40% of children with symptomatic cardiomyopathy undergo heart transplantation or die from cardiac complications within 2 years. However, a significant number of children suffering from cardiomyopathy are surviving into adulthood, making it an important chronic illness for both pediatric and adult clinicians to understand. The… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS